Business ❯ Corporate Governance ❯ Regulatory Compliance

Supply Chain Management

Human Rights Due Diligence Human Rights in Business Human Rights Compliance Bureaucracy Quality Control Third-Party Manufacturing

Telix Investors Face Jan. 9 Deadline in Securities Suit Over Drug and Manufacturing Disclosures

The case stems from regulatory disclosures by the SEC followed by the FDA that preceded double‑digit Telix ADS declines.

Telix Securities Suit Advances as Investor Firms Push Lead-Plaintiff Bids Before Jan. 9 Deadline